Bhawna Sirohi

6.7k total citations · 1 hit paper
171 papers, 3.8k citations indexed

About

Bhawna Sirohi is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bhawna Sirohi has authored 171 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Oncology, 41 papers in Hematology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bhawna Sirohi's work include Multiple Myeloma Research and Treatments (28 papers), Cancer Treatment and Pharmacology (19 papers) and Hematopoietic Stem Cell Transplantation (16 papers). Bhawna Sirohi is often cited by papers focused on Multiple Myeloma Research and Treatments (28 papers), Cancer Treatment and Pharmacology (19 papers) and Hematopoietic Stem Cell Transplantation (16 papers). Bhawna Sirohi collaborates with scholars based in India, United Kingdom and United States. Bhawna Sirohi's co-authors include R Powles, Seema Singhal, C Horton, Jayesh Mehta, S Kulkarni, J Treleaven, Shailesh V. Shrikhande, Radovan Sašo, Samar Kulkarni and Diana Tait and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bhawna Sirohi

159 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of gastric cancer in Asia: resource-stratified guidelines

2013 384 citations Bhawna Sirohi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bhawna Sirohi India	33	1.7k	1.2k	817	792	514	171	3.8k
Jon P. Gockerman United States	36	1.5k 0.9×	1.1k 0.9×	836 1.0×	636 0.8×	359 0.7×	128	4.4k
Vincent J. Picozzi United States	32	3.2k 1.9×	545 0.5×	619 0.8×	951 1.2×	792 1.5×	130	4.5k
Dianne Pulte United States	31	1.4k 0.9×	1.4k 1.1×	1.0k 1.2×	402 0.5×	308 0.6×	87	3.5k
Gerardo Colón‐Otero United States	30	2.0k 1.2×	407 0.3×	595 0.7×	608 0.8×	618 1.2×	99	3.5k
Glenn Mills United States	26	1.9k 1.1×	428 0.4×	673 0.8×	930 1.2×	340 0.7×	119	3.4k
Claudia Allemani United Kingdom	28	2.3k 1.4×	466 0.4×	515 0.6×	731 0.9×	486 0.9×	84	4.3k
Scot C. Remick United States	38	2.8k 1.6×	470 0.4×	1.5k 1.9×	1.0k 1.3×	656 1.3×	156	6.1k
Ralph M. Meyer Canada	36	1.7k 1.0×	1.5k 1.2×	449 0.5×	827 1.0×	606 1.2×	139	4.7k
Craig Underhill Australia	30	2.2k 1.3×	321 0.3×	609 0.7×	1.2k 1.5×	723 1.4×	129	3.7k
Vivek Roy United States	40	2.4k 1.4×	2.8k 2.4×	2.9k 3.5×	1.5k 1.9×	664 1.3×	203	6.1k

Countries citing papers authored by Bhawna Sirohi

Since Specialization

Citations

This map shows the geographic impact of Bhawna Sirohi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhawna Sirohi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhawna Sirohi more than expected).

Fields of papers citing papers by Bhawna Sirohi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhawna Sirohi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhawna Sirohi. The network helps show where Bhawna Sirohi may publish in the future.

Co-authorship network of co-authors of Bhawna Sirohi

This figure shows the co-authorship network connecting the top 25 collaborators of Bhawna Sirohi. A scholar is included among the top collaborators of Bhawna Sirohi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhawna Sirohi. Bhawna Sirohi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sirohi, Bhawna, Ghassan K. Abou‐Alfa, Hop S. Tran Cao, et al.. (2025). Neoadjuvant treatment for incidental gallbladder cancer: A systematic review. Annals of Hepato-Biliary-Pancreatic Surgery. 29(2). 113–120.

Datta, Soumitra Shankar, et al.. (2025). Qualitative study of oncologists’ perceptions on the US Food and Drug Administration approval status and clinical practice guidelines and their impact on local practice patterns in India. PubMed. 4(1). e000863–e000863.

Thaker, Premal H., Farzana Begum, Naresh Ramarajan, et al.. (2024). Abstract PO4-10-10: NAVYA-AI enabled intervention to increase real-world guideline compliant care: Improving NGS testing in breast cancer. Cancer Research. 84(9_Supplement). PO4–10.

Datta, Soumitra Shankar, et al.. (2024). What constitutes meaningful benefit of cancer drugs in the context of LMICs? A mixed-methods study of oncologists’ perceptions on endpoints, benefit, price, and value of cancer drugs. ESMO Open. 9(11). 103976–103976. 1 indexed citations

Sirohi, Bhawna, Noam Pondé, Mariana Brandão, et al.. (2020). 8P Knowledge, practice and attitudes of physicians in low- and middle-income countries (LMIC) on fertility and pregnancy-related issues in young breast cancer patients. Annals of Oncology. 31. S1245–S1245. 1 indexed citations

Mehrotra, Ravi, Sonam Tulsyan, Showket Hussain, et al.. (2018). Genetic landscape of gallbladder cancer: Global overview. Mutation Research/Reviews in Mutation Research. 778. 61–71. 37 indexed citations

Dawood, Shaheenah & Bhawna Sirohi. (2015). Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer. Future Oncology. 11(6). 923–931. 10 indexed citations

Sirohi, Bhawna, et al.. (2015). Molecular target therapy for gastrointestinal stromal tumors. 4(3). 207–218. 1 indexed citations

Sirohi, Bhawna. (2011). HPV in head and neck cancer. SHILAP Revista de lepidopterología.

10.

Jackson, Christopher B., Bhawna Sirohi, David Cunningham, et al.. (2010). Lymphocyte-predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience. Annals of Oncology. 21(10). 2061–2068. 42 indexed citations

11.

Sirohi, Bhawna, R Powles, Dana J. Lawrence, et al.. (2007). An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-α2b in patients with multiple myeloma maintained on a steady dose of interferon-α2b. Annals of Oncology. 18(8). 1388–1394. 19 indexed citations

12.

Sirohi, Bhawna & R Powles. (2007). Management of multiple myeloma. European Journal of Cancer Care. 17(1). 2–2. 1 indexed citations

13.

Sirohi, Bhawna, S. Ashley, Alison Norton, et al.. (2007). Early Response to Platinum-Based First-Line Chemotherapy in Non-small Cell Lung Cancer May Predict Survival. Journal of Thoracic Oncology. 2(8). 735–740. 28 indexed citations

14.

Arkenau, Hendrik‐Tobias, Geoffrey Chong, David Cunningham, et al.. (2006). The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Annals of Oncology. 18(3). 541–545. 63 indexed citations

15.

Sirohi, Bhawna, R Powles, Rajesh Chopra, et al.. (2006). A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplantation. 38(1). 47–51. 68 indexed citations

16.

Alvares, Caroline, Faith E. Davies, C Horton, et al.. (2005). Long‐term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high‐dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments. British Journal of Haematology. 129(5). 607–614. 32 indexed citations

17.

Singhal, Seema, R Powles, P. Jean Henslee‐Downey, et al.. (2002). Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplantation. 29(4). 291–295. 25 indexed citations

18.

Powles, R, Jayesh Mehta, Samar Kulkarni, et al.. (2000). Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. The Lancet. 355(9211). 1231–1237. 268 indexed citations

19.

Singhal, Seema, R Powles, S Kulkarni, et al.. (2000). Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Bone Marrow Transplantation. 25(5). 501–505. 36 indexed citations

20.

Singhal, Seema, R Powles, J Treleaven, et al.. (2000). A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?. Bone Marrow Transplantation. 26(5). 489–496. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact